Ra Medical Systems, Inc. (NYSE:RMED) is reporting second quarter earnings results on Tuesday 11th August 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.22 per share.
For the full year, analysts predict revenues of $ 4.54 million, while looking forward to loss of $ 0.89 per share.
Previous Quarter Performance
Ra Medical Systems, Inc. revealed loss for the first quarter of $ 0.56 per share, from the revenue of $ 1.37 million. Wall street analysts are predicting, RMED to report 1Q20 loss of $ 0.34 per share from revenue of $ 1.58 million. The bottom line results missed street analysts by $ 0.22 or 64.71 percent, at the same time, top line results fell short of analysts by $ 0.21 million or 13.29 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Ra Medical Systems, Inc.
Stock Performance
According to the previous trading day, closing price of RMED was $ 0.37, representing a 32.14 % increase from the 52 week low of $ 0.28 and a 86.25 % decrease over the 52 week high of $ 2.69.
The company has a market capital of $ 12.81 million and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”RMED” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
Ra Medical Systems, Inc. will be hosting a conference call at 4:30 PM eastern time on 11th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.ramed.com
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders.
